Co-Founder and CEO of Persephone Biosciences

San Diego, CA
Joined March 2016
How the Microbiome Could Be the Key to New Cancer Treatments po.st/rVBaqj via @SmithsonianMag
2
5
2
30
Why is #colorectalcancer research so important? Early-onset #CRC is on the rise, while survival rates remain low. But early detection can > survival by 77%. Schedule a #colonoscopy & sign up for the #ARGONAUT study to protect your health & help science. argonautvirtualtrial.com
2
2
Contribute to public health while protecting yours! You can help us better understand and treat #colorectalcancer by participating in the #ARGONAUT study during your routine #colonoscopy. Learn more: argonautvirtualtrial.com #crcsm #GetScreened @JanssenUS
1
1
Could the composition of the #microbiome in early life be contributing to an emerging rise in early-onset #cancer? Researchers from @harvardmed and @BrighamWomens examine the potential reasons behind a dramatic rise in cancer in people under 50. ow.ly/7yh850KHHa8
1
2
Stephanie Culler retweeted
The #microbiome is associated with virtually every disease we know and it lives in the gut. @PersephoneBio CEO @StephJCuller tells us how studying stool samples💩 can help scientists develop ways to fight disease. #NYSEFloorTalk
1
5
2
12
Participate in @PersephoneBio's clinical research study focused on infant gut health by donating a sample of your baby’s poop to help us develop treatments to support a healthy gut microbiome. Register at persephonebiosciences.com/my… businesswire.com/news/home/2…
4
7
Where is Persephone going next? @StephJCuller gives @sdut readers a sneak peek into our next indication, alongside oncology.
Can bacteria in your gut boost cancer therapies? A San Diego startup thinks so dlvr.it/SV9mGs
1
1
4
🎉 Happy birthday to us! And we're celebrating the 5yr anniversary of our founding with a great gift from forward-thinking investors who are committed to the vast potential of our #AI platform & #synbio tech: $15 million in financing. 🎉 Read more: ow.ly/HNxn50JYTwl
4
2
11
Could the efficacy of #COVID19 vaccines and therapy be improved by strengthening the #microbiome of patients whose gut health is out of balance? There's a lot of evidence that says yes, and here's how it could be done: ow.ly/v13y50J68VL
1
1
Stephanie Culler retweeted
Hey Twitter! We’re the VOICES Study team, and we’re so excited to share our program with you. VOICES is a compensated clinical study aimed at involving historically-excluded minority groups in the creation of novel medicines. Enroll now! #JoinVOICES #HealthEquity #microbiome
2
5
We are excited to be featured in the most recent edition of GEN. Read full article: genengnews.com/gen-edge/23-t…
1
1
We recently initiated the ARGONAUT Study, the largest ever clinical study to map the cancer gut microbiome immune axis in the U.S. @PersephoneBio is actively seeking investigators in oncology to collaborate in this ground-breaking study. For more info: persephonebiosciences.com/ar…
1
3
The world needs more women-led companies. On November 18th, join YC for their first Future Founder Conference, a virtual event for women globally and learn how to start a startup from inspiring entrepreneurs: ffc2020.ycombinator.com/
2
#BLUEKNIGHT aims to stimulate the innovation & incubation of potential solutions to protect our communities. Learn more about this collaboration between @JLABS & @BARDA: bit.ly/3llMbe9
9
1
10
#JNJInnovation & @BARDA select first cohort of @JLABS companies with the aim to combat #COVID19 as part of the #BLUEKNIGHT collaboration: jnjinnovation.com/node/blog-…
1
20
6
31
Stephanie Culler retweeted
Curebase in the news! Excited to have @GeneOnlineNews cover our story on CURE-19 and at-home COVID-19 clinical research. #clinicaltrials #covid19research geneonline.news/en/2020/05/0…
5
6
Stephanie Culler retweeted
Curebase is announcing the launch of CURE-19, a platform for at-home COVID-19 clinical trials. We've been live since Friday and already have hundreds of patients on the platform. #researchathome #covid19 #clinicaltrials web.curebase.com/blog/introd…
2
9
4
7
Today, we are proud to announce our intent to develop an AI-driven immune-boosting microbiome therapeutic to help prevent and fight #COVID19 #JLABS prnewswire.com/news-releases…